• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在奥拉帕尼敏感的BRCA缺陷型结直肠癌细胞模型中,持续性双链断裂积累并非先于细胞死亡发生。

Persistent double strand break accumulation does not precede cell death in an Olaparib-sensitive BRCA-deficient colorectal cancer cell model.

作者信息

Paviolo Natalia Soledad, Vega María Belén de la, Pansa María Florencia, García Iris Alejandra, Calzetta Nicolás Luis, Soria Gastón, Gottifredi Vanesa

机构信息

Fundación Instituto Leloir-Instituto de Investigaciones Bioquímicas de Buenos Aires. Buenos Aires, Argentina.

Centro de Investigaciones en Bioquímica Clínica e Inmunología, CIBICI-CONICET. Córdoba, Argentina.

出版信息

Genet Mol Biol. 2019 Dec 13;43(1 suppl 1):e20190070. doi: 10.1590/1678-4685-GMB-2019-0070. eCollection 2019.

DOI:10.1590/1678-4685-GMB-2019-0070
PMID:31930278
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7198003/
Abstract

The poly (adenosine diphosphate (ADP)-ribosyl) polymerase inhibitors (PARPi) selectively kill cancer cells with BRCA1 or BRCA2 (BRCA)-mutations. It has been proposed that cell death induction after PARPi depends on unrepaired double strand breaks (DSBs) that accumulate due to the homologous recombination deficiency of BRCA-mutated cells. Such accumulation of DSBs is inferred mainly from the high levels of DNA damage markers like phosphorylated histone H2AX. Herein, we developed a model of isogenic cell lines to show that depletion of BRCA causes PARPi-triggered cell death, replication stress (phosphorylated-H2AX and 53BP1 foci), and genomic instability. However, persistent DSBs accumulation was not detected under the same experimental conditions. Hence, at least in this cellular model, the trigger for cell death in PARPi-treated BRCA-depleted samples is not the accumulation of unrepaired DSBs. Instead, cell death better correlates with a rapid and aberrant resolution of DSBs by error-prone pathways that leads to severe chromosomic aberrations. Therefore, our results suggest that in PARPi-treated BRCA-deficient cells, chromosome aberrations may dually trigger both genomic instability and cell death.

摘要

聚(腺苷二磷酸(ADP)-核糖基)聚合酶抑制剂(PARPi)可选择性杀死具有BRCA1或BRCA2(BRCA)突变的癌细胞。有人提出,PARPi处理后细胞死亡的诱导取决于由于BRCA突变细胞的同源重组缺陷而积累的未修复双链断裂(DSB)。这种DSB的积累主要是从诸如磷酸化组蛋白H2AX等高水平DNA损伤标志物推断出来的。在此,我们建立了一个同基因细胞系模型,以表明BRCA的缺失会导致PARPi触发细胞死亡、复制应激(磷酸化-H2AX和53BP1灶)和基因组不稳定。然而,在相同实验条件下未检测到持续性DSB积累。因此,至少在这个细胞模型中,PARPi处理的BRCA缺失样本中细胞死亡的触发因素不是未修复DSB的积累。相反,细胞死亡与通过易出错途径快速异常修复DSB导致严重染色体畸变的情况更好相关。因此,我们的结果表明,在PARPi处理的BRCA缺陷细胞中,染色体畸变可能双重触发基因组不稳定和细胞死亡。

相似文献

1
Persistent double strand break accumulation does not precede cell death in an Olaparib-sensitive BRCA-deficient colorectal cancer cell model.在奥拉帕尼敏感的BRCA缺陷型结直肠癌细胞模型中,持续性双链断裂积累并非先于细胞死亡发生。
Genet Mol Biol. 2019 Dec 13;43(1 suppl 1):e20190070. doi: 10.1590/1678-4685-GMB-2019-0070. eCollection 2019.
2
Pharmacological ascorbate induces 'BRCAness' and enhances the effects of Poly(ADP-Ribose) polymerase inhibitors against BRCA1/2 wild-type ovarian cancer.药理剂量的维生素C诱导“BRCA样状态”并增强聚(ADP-核糖)聚合酶抑制剂对BRCA1/2野生型卵巢癌的疗效。
Oncol Lett. 2020 Apr;19(4):2629-2638. doi: 10.3892/ol.2020.11364. Epub 2020 Jan 31.
3
Harnessing DNA Double-Strand Break Repair for Cancer Treatment.利用DNA双链断裂修复进行癌症治疗。
Front Oncol. 2019 Dec 10;9:1388. doi: 10.3389/fonc.2019.01388. eCollection 2019.
4
Synergistic loss of prostate cancer cell viability by coinhibition of HDAC and PARP.联合抑制组蛋白去乙酰化酶和 PARP 可协同降低前列腺癌细胞活力。
Mol Cancer Res. 2014 Dec;12(12):1755-66. doi: 10.1158/1541-7786.MCR-14-0173. Epub 2014 Aug 15.
5
Poly (ADP-ribose) polymerase inhibitor efficacy in head and neck cancer.聚(ADP - 核糖)聚合酶抑制剂在头颈癌中的疗效
Oral Oncol. 2014 Sep;50(9):825-31. doi: 10.1016/j.oraloncology.2014.06.004. Epub 2014 Jul 10.
6
Synthetic lethality between BRCA1 deficiency and poly(ADP-ribose) polymerase inhibition is modulated by processing of endogenous oxidative DNA damage.BRCA1 缺陷与聚(ADP-核糖)聚合酶抑制之间的合成致死性受内源性氧化 DNA 损伤的处理调节。
Nucleic Acids Res. 2019 Sep 26;47(17):9132-9143. doi: 10.1093/nar/gkz624.
7
Advances and perspectives of PARP inhibitors.聚(ADP - 核糖)聚合酶抑制剂的进展与前景
Exp Hematol Oncol. 2019 Nov 11;8:29. doi: 10.1186/s40164-019-0154-9. eCollection 2019.
8
BRCA1 and BRCA2 protect against oxidative DNA damage converted into double-strand breaks during DNA replication.BRCA1和BRCA2可防止在DNA复制过程中转化为双链断裂的氧化性DNA损伤。
DNA Repair (Amst). 2015 Jun;30:11-20. doi: 10.1016/j.dnarep.2015.03.002. Epub 2015 Mar 17.
9
Dual disruption of DNA repair and telomere maintenance for the treatment of head and neck cancer.双重破坏 DNA 修复和端粒维持以治疗头颈部癌症。
Clin Cancer Res. 2014 Dec 15;20(24):6465-78. doi: 10.1158/1078-0432.CCR-14-0176. Epub 2014 Oct 16.
10
Epigenetically Downregulated Breast Cancer Gene 2 through Acetyltransferase Lysine Acetyltransferase 2B Increases the Sensitivity of Colorectal Cancer to Olaparib.通过乙酰转移酶赖氨酸乙酰转移酶2B表观遗传下调的乳腺癌基因2增加结直肠癌对奥拉帕利的敏感性。
Cancers (Basel). 2023 Nov 25;15(23):5580. doi: 10.3390/cancers15235580.

引用本文的文献

1
Dissecting the cell cycle regulation, DNA damage sensitivity and lifespan effects of caffeine in fission yeast.剖析咖啡因在裂殖酵母中的细胞周期调控、DNA损伤敏感性及寿命影响。
Microb Cell. 2025 Jun 24;12:141-156. doi: 10.15698/mic2025.06.852. eCollection 2025.
2
Bioinformatics-based identification of key genes for Olaparib resistance in breast cancer: prognostic implications and therapeutic relevance.基于生物信息学鉴定乳腺癌中奥拉帕尼耐药的关键基因:预后意义及治疗相关性
Discov Oncol. 2025 Jun 18;16(1):1144. doi: 10.1007/s12672-025-02989-z.
3
Systemic DNA Damage and Repair Activity Vary by Race in Breast Cancer Survivors.

本文引用的文献

1
Polo-like Kinase 1 Inhibition as a Therapeutic Approach to Selectively Target BRCA1-Deficient Cancer Cells by Synthetic Lethality Induction.通过诱导合成致死作用,抑制Polo样激酶1作为一种治疗方法,用于选择性靶向BRCA1缺陷的癌细胞。
Clin Cancer Res. 2019 Jul 1;25(13):4049-4062. doi: 10.1158/1078-0432.CCR-18-3516. Epub 2019 Mar 19.
2
A comparative pharmacokinetic study of PARP inhibitors demonstrates favorable properties for niraparib efficacy in preclinical tumor models.一项PARP抑制剂的比较药代动力学研究表明,在临床前肿瘤模型中,尼拉帕利的疗效具有良好特性。
Oncotarget. 2018 Dec 14;9(98):37080-37096. doi: 10.18632/oncotarget.26354.
3
乳腺癌幸存者的全身DNA损伤与修复活性因种族而异。
Cancers (Basel). 2024 May 9;16(10):1807. doi: 10.3390/cancers16101807.
4
RAD51 separation of function mutation disables replication fork maintenance but preserves DSB repair.RAD51功能分离突变会使复制叉维持功能失效,但能保留双链断裂修复功能。
iScience. 2024 Mar 16;27(4):109524. doi: 10.1016/j.isci.2024.109524. eCollection 2024 Apr 19.
5
The Influence of PARP, ATR, CHK1 Inhibitors on Premature Mitotic Entry and Genomic Instability in High-Grade Serous and Ovarian Cancer Cells.聚腺苷二磷酸核糖聚合酶(PARP)、ATR、CHK1 抑制剂对高级别浆液性和卵巢癌细胞过早有丝分裂进入和基因组不稳定性的影响。
Cells. 2022 Jun 10;11(12):1889. doi: 10.3390/cells11121889.
6
Fanconi Anemia Pathway in Colorectal Cancer: A Novel Opportunity for Diagnosis, Prognosis and Therapy.范可尼贫血通路在结直肠癌中的作用:诊断、预后及治疗的新契机
J Pers Med. 2022 Mar 4;12(3):396. doi: 10.3390/jpm12030396.
7
BRCA mutations and gastrointestinal cancers: When to expect the unexpected?BRCA基因突变与胃肠道癌症:何时会出现意外情况?
World J Clin Oncol. 2021 Jul 24;12(7):565-580. doi: 10.5306/wjco.v12.i7.565.
ATM orchestrates the DNA-damage response to counter toxic non-homologous end-joining at broken replication forks.
ATM 协调 DNA 损伤反应以对抗断裂复制叉处的有毒非同源末端连接。
Nat Commun. 2019 Jan 8;10(1):87. doi: 10.1038/s41467-018-07729-2.
4
Loss of E2F7 confers resistance to poly-ADP-ribose polymerase (PARP) inhibitors in BRCA2-deficient cells.E2F7 的缺失赋予了 BRCA2 缺陷细胞对聚 ADP-核糖聚合酶(PARP)抑制剂的耐药性。
Nucleic Acids Res. 2018 Sep 28;46(17):8898-8907. doi: 10.1093/nar/gky657.
5
Selective Loss of PARG Restores PARylation and Counteracts PARP Inhibitor-Mediated Synthetic Lethality.选择性缺失 PARG 可恢复 PAR 化并拮抗 PARP 抑制剂介导的合成致死性。
Cancer Cell. 2018 Jun 11;33(6):1078-1093.e12. doi: 10.1016/j.ccell.2018.05.008.
6
Multifaceted Impact of MicroRNA 493-5p on Genome-Stabilizing Pathways Induces Platinum and PARP Inhibitor Resistance in BRCA2-Mutated Carcinomas.miRNA 493-5p 通过影响基因组稳定途径对 BRCA2 突变型癌产生铂类和 PARP 抑制剂耐药的多方面影响。
Cell Rep. 2018 Apr 3;23(1):100-111. doi: 10.1016/j.celrep.2018.03.038.
7
EZH2 promotes degradation of stalled replication forks by recruiting MUS81 through histone H3 trimethylation.EZH2 通过招募 MUS81 并通过组蛋白 H3 三甲基化促进停滞复制叉的降解。
Nat Cell Biol. 2017 Nov;19(11):1371-1378. doi: 10.1038/ncb3626. Epub 2017 Oct 16.
8
Beyond interstrand crosslinks repair: contribution of FANCD2 and other Fanconi Anemia proteins to the replication of DNA.超越链间交联修复:FANCD2及其他范可尼贫血蛋白对DNA复制的作用
Mutat Res. 2018 Mar;808:83-92. doi: 10.1016/j.mrfmmm.2017.09.004. Epub 2017 Sep 14.
9
BRCA2 suppresses replication stress-induced mitotic and G1 abnormalities through homologous recombination.BRCA2通过同源重组抑制复制应激诱导的有丝分裂和G1期异常。
Nat Commun. 2017 Sep 13;8(1):525. doi: 10.1038/s41467-017-00634-0.
10
ATM Deficiency Generating Genomic Instability Sensitizes Pancreatic Ductal Adenocarcinoma Cells to Therapy-Induced DNA Damage.ATM 缺陷导致基因组不稳定性使胰腺导管腺癌细胞对治疗诱导的 DNA 损伤敏感。
Cancer Res. 2017 Oct 15;77(20):5576-5590. doi: 10.1158/0008-5472.CAN-17-0634. Epub 2017 Aug 8.